Navigation Links
Endo Pharmaceuticals Announces Proposal to Change Name of Parent Company and Rebrands Enterprise: Revealing an Innovative Corporate Structure Dedicated to Redefining Healthcare Value
Date:3/1/2012

be setting a new standard for healthcare solutions delivery.  Our parent company's new name, which we propose to be 'Endo Health Solutions Inc.' should help clarify our corporate identity, making it clear to people how to refer to our operating companies and how to refer to the parent company," he said.

Mr. Holveck, who took the helm of Endo Pharmaceuticals in 2008, worked with the board of directors to set a new strategic direction for that company. This new vision required the reinvention of the company's business model with deeper immersion in key therapeutic pathways and greater offerings that could capitalize on the intersection of healthcare access, economics and outcomes.

This unique approach to aggregating healthcare information and treatments opens the door to greater levels of innovation and collaboration among the operating companies and their customers, in an effort to meet the varying needs of all stakeholders in the healthcare system: patients, physicians and payers.

"Our philosophy of combining branded drugs, generic drugs, devices and services, including diagnostics and data, aims to create maximum choice and value for all participants in the healthcare continuum, and our strategy is founded in the balance of cost and benefit," continued Mr. Holveck. "A key focus for the next several years will be fully integrating these solutions into true, packaged offerings and filling the existing gaps in pain and urology management."

The new enterprise architecture and naming structure is an appropriate representation of the framework of operations and enables the company to leverage the well-known brand equity that exists with each operating company, while supporting efforts toward continually becoming more customer-focused.  The operating companies' franchise brands will share visual and verbal identity standards to the parent brand:

  • AMS, which develops structural device therapi
    '/>"/>

SOURCE Endo Pharmaceuticals Holdings Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
2. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
3. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
4. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
5. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
6. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
7. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
8. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
9. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
10. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
11. Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase III Clinical Trial for Lead Aversion(R) Technology Product Candidate
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... , Aug. 28, 2015 ... announced the addition of the "Investigation Report ... their offering. Developed by Pharmacia & ... receptor agonist which effectively reduces intraocular pressure. As ... latanoprost (under the trade name of Xalatan) entered ...
(Date:8/28/2015)... , August 28, 2015 The ... in collaboration with one of the leading academics in the ... (current world record holder in life extension for model animals ... into biology of aging and age-related diseases, primarily, around the ... work has just been published as "Stability analysis of a ...
(Date:8/28/2015)... 28, 2015 Perrigo Company plc ("Perrigo") (NYSE: ... N.V. ("Mylan") (NASDAQ: MYL ) shareholder vote regarding ... "Our views of Mylan,s offer to Perrigo shareholders have ... our Board,s careful reflection of the value available to ... choices that Mylan has allowed its shareholders to consider," ...
Breaking Medicine Technology:China Latanoprost Market Investigation Report 2015-2019 2Gero: Physics Meets Biology to Help Defeat Aging 2Gero: Physics Meets Biology to Help Defeat Aging 3Perrigo Confident Its Shareholders Will Reject Mylan's Value Destructive Transaction 2Perrigo Confident Its Shareholders Will Reject Mylan's Value Destructive Transaction 3Perrigo Confident Its Shareholders Will Reject Mylan's Value Destructive Transaction 4Perrigo Confident Its Shareholders Will Reject Mylan's Value Destructive Transaction 5
... , BELLEVUE, Wash., Dec. 1 ... of health, beauty, vision, and pharmacy products, today announced that ... were the highest in company history. This holiday season the ... more special offers than in previous years and their largest ...
... , NEW YORK, ... research report is available in its catalogue: , ... http://www.reportlinker.com/p0164231/Molecular-Diagnostics---A-World-Market-Review.html , Molecular diagnostics market is being ... for automated and easy-to-handle techniques, which combine optimized sample ...
Cached Medicine Technology:drugstore.com, inc. Has Best Day Ever on Cyber Monday 2drugstore.com, inc. Has Best Day Ever on Cyber Monday 3Reportlinker Adds Molecular Diagnostics - A World Market Review 2Reportlinker Adds Molecular Diagnostics - A World Market Review 3Reportlinker Adds Molecular Diagnostics - A World Market Review 4Reportlinker Adds Molecular Diagnostics - A World Market Review 5Reportlinker Adds Molecular Diagnostics - A World Market Review 6Reportlinker Adds Molecular Diagnostics - A World Market Review 7
(Date:8/29/2015)... ... August 29, 2015 , ... People who have heart or ... or asthma, are at higher risk from wildfire smoke especially in Calgary, Alberta.Those ... heart-rhythm problems (arrhythmia or irregular heartbeat) are also sensitive to air pollution. ...
(Date:8/29/2015)... ... August 29, 2015 , ... Vascular Health Sciences ... sell Arterosil and Arterosil HP, and that all claims and counterclaims have been ... Sciences, LLC (VHS) in the United States District Court for the Southern District ...
(Date:8/28/2015)... ... August 28, 2015 , ... An online provider of CPAP machines, masks, supplies, ... CPAP equipment more affordable by offering shipping at no cost to you, directly to ... orders of any size. My Cpap Store is located in Las Vegas, Nevada. , ...
(Date:8/28/2015)... ... 28, 2015 , ... An article published August 19th by the ... gone through to open a pizzeria in Westchester. Mr. LaRocco was aware from opening ... months, but the current process, having already gone on for over a year, is ...
(Date:8/28/2015)... Falls Church, VA (PRWEB) , ... ... ... and Cybersecurity Risk Management for Medical Devices:, Understanding the FDA’s Position and ... – Rockville, MD, http://www.fdanews.com/cybersecuritymd , This workshop, chaired by internationally ...
Breaking Medicine News(10 mins):Health News:Heart Fit Clinic Sounds the Alarm on Forest Fire Smoke and Chronic Heart Disease in Calgary Area 2Health News:My Cpap Store Now Offering Delivery Special 0 Cost to You 2Health News:Article on Building Approval Process for LA Business Highlights the Need for a Bridge Between Businesses and City Officials, says Fire Protection Group Inc. 2Health News:FDAnews Announces — Software and Cybersecurity Risk Management for Medical Devices: Understanding the FDA’s Position and Best Practices for Compliance, Oct. 14-15 2Health News:FDAnews Announces — Software and Cybersecurity Risk Management for Medical Devices: Understanding the FDA’s Position and Best Practices for Compliance, Oct. 14-15 3Health News:FDAnews Announces — Software and Cybersecurity Risk Management for Medical Devices: Understanding the FDA’s Position and Best Practices for Compliance, Oct. 14-15 4Health News:FDAnews Announces — Software and Cybersecurity Risk Management for Medical Devices: Understanding the FDA’s Position and Best Practices for Compliance, Oct. 14-15 5
... ventromedial prefrontal cortex may be associated with how people ... event.// ,Researchers from Massachusetts General Hospital have ... factor that affects the incidence of people developing anxiety ... , ,People who go through an intense and ...
... death was reported after being given an unauthorized Hepatitis A ... province of Anhui were administered the Hepatitis A vaccine on ... ,Li Wei a six-year-old child suffered an unspecified infection ... following which she died a few days later. Some of ...
... risk of cellular rejection after a heart transplant// ... ,The drug, a humanized monoclonal antibody, is directed ... ,Patients who were taken into the Study ... ,The primary endpoint was a composite of moderate ...
... 75 million people in the United States, Europe and Japan ... recommended that drinking calcium water may help in reducing osteoporosis., ... majority of the people do not consume enough of this ... individuals with osteoporosis but for many teenagers, and those in ...
... People who remain angry for considerable periood of time may ... ,Reserachers of University of California, Berkeley, had found that feeing ... like lowering of the immune functions, urge to pick up ... life. ,Reserachers who had done a survey of the ...
... consumption of fruits, vegetables and foods high in fibre can ... heart disease. ,Western cuisines are not so high in ... in the diet. ,10 healthy individuals were taken as ... of them. The diets were a vegetarian diet rich in ...
Cached Medicine News:Health News:Fibre Rich Food A Boon For Lowering Cholesterol 2
... Innovators in Anesthesia and Respiratory Products, ... medical devices for Anesthesia and Respiratory professionals. ... products that enhance the clinician's ability to ... attention to the bottom line. , ...
... Innovators in Anesthesia and Respiratory Products, ... quality medical devices for Anesthesia and Respiratory ... manufacture products that enhance the clinician's ability ... close attention to the bottom line. , ...
... optimum lung penetration for maximum therapeutic benefit. ... µ at 6-8 LPM. Latex-free components. Usable ... the world leader in airway management products, ... proven technology by offering top brands in ...
... makeshift, modified nebulizer setups to deliver CNT ... when your patient is critical? OMNI~MAX has ... in Heliox rescue therapy. In severe obstructive ... standard of care in hospitals across the ...
Medicine Products: